BioNTech SE ADR buy neoplast
Start price
16.12.22
/
50%
€168.55
Target price
16.01.23
€194.00
Performance (%)
-20.53%
End price
17.01.23
€133.95
Summary
This prediction ended on 17.01.23 with a price of €133.95. The price of BioNTech SE ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -20.53%. neoplast has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioNTech SE ADR | 7.896% | 7.896% | 243.124% |
| iShares Core DAX® | -3.935% | -3.998% | 11.192% |
| iShares Nasdaq 100 | -3.608% | -9.386% | 22.243% |
| iShares Nikkei 225® | -4.513% | -8.017% | 5.961% |
| iShares S&P 500 | -2.607% | -4.265% | 21.865% |
According to neoplast what are the pros and cons of BioNTech SE ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by neoplast for this prediction
In the thread Biontech SE diskutieren
Kursziel gesetzt auf 194,0
In the thread Trading Biontech SE
Die von neoplast gewählte maximale Laufzeit wurde überschritten